Belgium, July 2 -- Belgium based EG has secured contract from UZ Leuven for Pharmaceutical products - Supplying a reimbursed form of Bevacizumab 100 mg/4 ml and 400 mg/16 ml for intravenous use . The value of the contract is worth 837024 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....